Cargando…

Stability of mild cognitive impairment in newly diagnosed Parkinson's disease

BACKGROUND: Mild cognitive impairment (MCI) is common in early Parkinson's disease (PD). We evaluated the stability of PD-MCI over time to determine its clinical utility as a marker of disease. METHODS: 212 newly diagnosed participants with PD were recruited into a longitudinal study and reasse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lawson, Rachael A, Yarnall, Alison J, Duncan, Gordon W, Breen, David P, Khoo, Tien K, Williams-Gray, Caroline H, Barker, Roger A, Burn, David J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Movement Disorders
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537517/ https://www.ncbi.nlm.nih.gov/pubmed/28250029 http://dx.doi.org/10.1136/jnnp-2016-315099

Ejemplares similares

Anxiety is associated with cognitive impairment in newly-diagnosed Parkinson's disease
por: Dissanayaka, Nadeeka N.W., et al.
Publicado: (2017)

Impact of GBA1 variants on long-term clinical progression and mortality in incident Parkinson’s disease
por: Stoker, Thomas B, et al.
Publicado: (2020)

Features of GBA-associated Parkinson’s disease at presentation in the UK Tracking Parkinson’s study
por: Malek, Naveed, et al.
Publicado: (2018)

Genetics of validated Parkinson’s disease subtypes in the Oxford Discovery and Tracking Parkinson’s cohorts
por: Lawton, Michael, et al.
Publicado: (2022)

Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts
por: Swallow, Diane M A, et al.
Publicado: (2016)

Urate and Homocysteine: Predicting Motor and Cognitive Changes in Newly Diagnosed Parkinson’s Disease
por: Sleeman, Isobel, et al.
Publicado: (2019)

Clinical implications of early caudate dysfunction in Parkinson’s disease
por: Pasquini, Jacopo, et al.
Publicado: (2019)

Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression
por: Lawton, Michael, et al.
Publicado: (2018)

Systematic review of data‐driven cognitive subtypes in Parkinson disease
por: Pourzinal, Dana, et al.
Publicado: (2022)

The Addenbrooke's Cognitive Examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders
por: Rittman, Timothy, et al.
Publicado: (2013)

Severity of mild cognitive impairment in early Parkinson's disease contributes to poorer quality of life
por: Lawson, Rachael A., et al.
Publicado: (2014)

Combining biomarkers for prognostic modelling of Parkinson’s disease
por: Vijiaratnam, Nirosen, et al.
Publicado: (2022)

The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's disease
por: Barker, Roger A, et al.
Publicado: (2013)

Visual hallucinations in the differential diagnosis of parkinsonism
por: Bertram, Kelly, et al.
Publicado: (2012)

Using ‘dead or dependent’ as an outcome measure in clinical trials in Parkinson's disease
por: McGhee, David, et al.
Publicado: (2015)

The prediagnostic phase of Parkinson's disease
por: Noyce, Alastair John, et al.
Publicado: (2016)

Systematic clinical approach for diagnosing upper limb tremor
por: van de Wardt, Jaron, et al.
Publicado: (2020)

Pisa syndrome in Parkinson's disease: a mobile or fixed deformity?
por: Doherty, Karen M, et al.
Publicado: (2013)

Bone health in Parkinson's disease: a systematic review and meta-analysis
por: Torsney, Kelli M, et al.
Publicado: (2014)

How I treat Parkinson's disease
por: Barbosa, Egberto Reis, et al.
Publicado: (2022)

Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study
por: Moreau, Caroline, et al.
Publicado: (2013)

PREDICT-PD: Identifying risk of Parkinson's disease in the community: methods and baseline results
por: Noyce, Alastair J, et al.
Publicado: (2014)

Baseline and longitudinal grey matter changes in newly diagnosed Parkinson’s disease: ICICLE-PD study
por: Mak, Elijah, et al.
Publicado: (2015)

Parkinson’s disease determinants, prediction and gene–environment interactions in the UK Biobank
por: Jacobs, Benjamin Meir, et al.
Publicado: (2020)

Cortical thinning is associated with disease stages and dementia in Parkinson's disease
por: Zarei, Mojtaba, et al.
Publicado: (2013)

Bilateral adaptive deep brain stimulation is effective in Parkinson's disease
por: Little, Simon, et al.
Publicado: (2016)

Brain iron deposition is linked with cognitive severity in Parkinson’s disease
por: Thomas, George Edward Calver, et al.
Publicado: (2020)

Validation of new diagnostic criteria for fatigue in patients with Parkinson disease
por: Siciliano, Mattia, et al.
Publicado: (2022)

A composite clinical motor score as a comprehensive and sensitive outcome measure for Parkinson’s disease
por: Lo, Christine, et al.
Publicado: (2022)

Predictors of short-term impulsive and compulsive behaviour after subthalamic stimulation in Parkinson disease
por: Sauerbier, Anna, et al.
Publicado: (2021)

Induced pluripotent stem cells in Parkinson's disease: scientific and clinical challenges
por: Xiao, Bin, et al.
Publicado: (2016)

Comparative whole transcriptome analysis of Parkinson’s disease focusing on the efficacy of zonisamide
por: Naito, Tatsuhiko, et al.
Publicado: (2022)

Morphometric imaging and quantitative susceptibility mapping as complementary tools in the diagnosis of parkinsonisms
por: Mazzucchi, Sonia, et al.
Publicado: (2022)

Deep brain stimulation in Parkinson’s disease: state of the art and future perspectives
por: França, Carina, et al.
Publicado: (2022)

Which Neuropsychological Tests? Predicting Cognitive Decline and Dementia in Parkinson’s Disease in the ICICLE-PD Cohort
por: Lawson, Rachael A., et al.
Publicado: (2021)

Late onset depression: dopaminergic deficit and clinical features of prodromal Parkinson’s disease: a cross-sectional study
por: Kazmi, Hiba, et al.
Publicado: (2021)

Efficacy of intensive multidisciplinary rehabilitation in Parkinson’s disease: a randomised controlled study
por: Ferrazzoli, Davide, et al.
Publicado: (2018)

Long‐term independence and quality of life after subthalamic stimulation in Parkinson disease
por: Castrioto, Anna, et al.
Publicado: (2022)

Prognostic predictors relevant to end-of-life palliative care in Parkinson’s disease and related disorders: a systematic review
por: Akbar, Umer, et al.
Publicado: (2021)

Cognitive decline and quality of life in incident Parkinson's disease: The role of attention
por: Lawson, Rachael A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_uh8p7ahp96qcthtpt6tve3icaq